MedTrace Logo

Febrile Urinary Tract Infection Randomized Short Treatment Trial

NCT00809913 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-09-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether a 7-day duration of antibiotic treatment of febrile urinary tract infection (FUTI) is non inferior to 14-day standard duration of treatment in unselected population presenting at primary care or emergency department.

Conditions

Interventions

DRUG

short treatment (ciprofloxacin)

7 days of antibiotic treatment for febrile urinary tract infection / acute pyelonephritis compared to standard treatment of 14 days

Sponsors & Collaborators

  • Bronovo Hospital

    collaborator OTHER

  • Medical Center Haaglanden

    collaborator OTHER

  • Spaarne Gasthuis

    collaborator OTHER

  • Rijnland Hospital

    collaborator OTHER

  • Diaconessenhuis Leiden

    collaborator UNKNOWN

  • Groene Hart Ziekenhuis

    collaborator OTHER

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Jaap T. van Dissel, MD, PhD · Leiden University Medical Center

  • Cees van Nieuwkoop, MD, PhD · Leiden University Medical Center and Haga Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2013-05-31
Completion
2013-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00809913 on ClinicalTrials.gov